AI news ·
Pathos AI Raises $237 Million at $3 Billion Valuation
Pathos AI raised $237 million at a $3 billion valuation to expand its drug-development platform and advance its cancer treatment pipeline.

Pathos AI has closed a $237 million financing round, giving the company a post-money valuation of $3 billion. The capital will fund expansion of its drug-development platform and the advancement of its oncology pipeline.
The raise reflects continued investor appetite for companies that integrate computational models with proprietary clinical programs tied to measurable development milestones.